PT  - JOURNAL ARTICLE
AU  - Sauter, Thomas
AU  - Pacheco, Maria Pires
TI  - TESTING INFORMED SIR BASED EPIDEMIOLOGICAL MODEL FOR COVID-19 IN LUXEMBOURG
AID  - 10.1101/2020.07.21.20159046
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.21.20159046
4099  - http://medrxiv.org/content/early/2020/07/25/2020.07.21.20159046.short
4100  - http://medrxiv.org/content/early/2020/07/25/2020.07.21.20159046.full
AB  - The interpretation of the number of COVID-19 cases and deaths in a country or region is strongly dependent on the number of performed tests. We developed a novel SIR based epidemiological model (SIVRT) which allows the country-specific integration of testing information and other available data. The model thereby enables a dynamic inspection of the pandemic and allows estimating key figures, like the number of overall detected and undetected COVID-19 cases and the infection fatality rate. As proof of concept, the novel SIVRT model was used to simulate the first phase of the pandemic in Luxembourg. An overall number of infections of 13.000 and an infection fatality rate of 1,3% was estimated, which is in concordance with data from population-wide testing. Furthermore based on the data as of end of May 2020 and assuming a partial deconfinement, an increase of cases is predicted from mid of July 2020 on. This is consistent with the current observed rise and shows the predictive potential of the novel SIVRT model.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTS and MPP are funded by the University of Luxembourg.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study is performed on publically available and anonymous epidemiological data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFor Luxembourg data on people tested positive, death cases, hospitalisation and performed tests were obtained from the website of the Luxembourgish government https://coronavirus.gouvernement.lu/en.html and are summarized in Appendix 2 of this paper. https://coronavirus.gouvernement.lu/en.html